AleraCare and Pure Healthcare Complete Merger, Forming a National Powerhouse in Ambulatory Infusion and Specialty Care
AleraCare, a prominent national provider of infusion and specialty pharmacy services, and Pure Healthcare, a widely respected medical group known for delivering comprehensive care to patients with complex and chronic health conditions, have officially completed their previously announced merger. This strategic combination brings together two mission-driven healthcare organizations that share a common vision: to elevate the standard of care for patients who rely on advanced, high-touch therapies to manage challenging diseases.
Pure Healthcare’s clinical expertise spans a broad spectrum of chronic and autoimmune conditions—including rheumatoid arthritis, Crohn’s disease, multiple sclerosis, Alzheimer’s disease, and a wide range of immunologic and neurologic disorders. By merging with AleraCare, the two organizations will now operate as a unified platform capable of delivering integrated infusion, specialty pharmacy, and chronic-care services at unprecedented scale.
Uniting Two Patient-Centered Health Leaders
The merger represents a significant milestone for the U.S. infusion and specialty-care landscape. Together, AleraCare and Pure Healthcare bring a deep commitment to clinical excellence, cost-effective care delivery, and patient-centered service models. Their combination is designed to address the growing need for safe, efficient, and accessible care settings for high-acuity therapies—particularly as healthcare shifts away from hospital-based treatment toward more convenient and affordable outpatient and alternate-site options.
“Today marks a major step forward for patients, physicians, and our payor partners who depend on timely, coordinated access to advanced therapies,” said Joe Cosgrove, Chief Executive Officer of the newly combined company. “By uniting AleraCare and Pure Healthcare, we’re pairing world-class clinical talent with scalable operations and technology—so patients can start therapy sooner, providers can practice with confidence, and payors can realize meaningful value in the right site of care. Our shared culture is built on clinical excellence, accountability, and empathy; that’s what will power our next chapter.”
The merger is expected to equip the combined organization with enhanced operational capabilities and expanded geographic reach, enabling it to better meet the needs of patients requiring treatment for highly complex health conditions. The move also strengthens the company’s ability to support physicians with streamlined referral pathways, reliable communication, and robust clinical coordination.
Investor Perspective: A Platform Built for Scale and Outcomes
The transaction is backed by leading healthcare investors who see strong potential for growth, innovation, and improved patient outcomes.
“This combination creates one of the most capable, patient-centered infusion and specialty-care platforms in the country,” said Andrew Goldman, Co-Founder and Managing Partner at Hildred. “AleraCare and Pure Healthcare share a commitment to clinical excellence, operational discipline, and delivering therapies in the most effective setting.”
Stephen Hallenbeck, Partner at Hildred, added, “We look forward to supporting the team as they continue expanding access, strengthening provider partnerships, and driving value for patients and payors nationwide.”
The involvement of Hildred signals ongoing investment in building a high-performance organization positioned to meet the rising demand for infusion and specialty care—one of the fastest-growing sectors in U.S. healthcare.
A Culture Built on Compassion and Operational Excellence
Pure Healthcare’s leadership emphasized that the merger is not only about scale, but about strengthening a culture that prioritizes patients and the clinicians who care for them.
“We are proud to partner with Hildred to accelerate the growth of a national platform built on what has always defined Pure Healthcare—our patient-obsessed culture,” said Josh Tandy, Managing Partner at Build Capital Partners. “By doing what is right for the patient and being strong partners to the specialists, pharmaceutical innovators, supply organizations, and technology teams that support their care, we will continue to define the standard for excellence across the industry.”
This philosophy aligns strongly with AleraCare’s longstanding focus on compassionate, coordinated care. Together, the organizations aim to deliver more integrated clinical experiences while reducing the administrative burden on providers and improving affordability for patients and payors.
Key Benefits of the Combined Organization
The newly merged company unlocks significant advantages for patients, referring physicians, payors, and biopharma partners. Among the most notable benefits are:
1. National Reach and Operational Scale
The combined footprint spans 14 states and includes 77 ambulatory infusion centers, with additional growth planned across both home-based and alternate-site care settings. This unified scale allows the company to deliver consistent clinical quality, reduce time-to-therapy, and reach underserved regions.
2. Broad and Comprehensive Therapy Portfolio
The organization will offer an expanded suite of therapies across immunology, neurology, gastroenterology, rheumatology, ophthalmology, and other complex disease areas. Patients with chronic and rare conditions will benefit from improved access to advanced treatments delivered in the most appropriate care environment.
3. Integrated Partner Network
By streamlining contracting and operational infrastructure, the merged company will provide a single, cohesive platform for payors, providers, and biopharma manufacturers. This integration is expected to accelerate benefits verification, optimize site-of-care decisions, and improve patient adherence to prescribed therapies.
4. Technology and Data Innovation
The organization will leverage AI-enabled platforms for scheduling, benefits investigation, authorization support, and real-time outcomes tracking. These tools are designed to reduce administrative delays, personalize care coordination, and ensure timely intervention when patients need clinical support.
5. Strengthened Team and Unified Mission
The company’s combined workforce brings together clinicians, pharmacists, technicians, care coordinators, and administrative experts under one unified mission: delivering safe, compassionate, and high-quality care. This alignment is critical for maintaining superior patient experiences and building trust with providers.
Integration Efforts Already Underway
The company has initiated a comprehensive integration program focused on ensuring continuity of care and maintaining strong communication with key stakeholders. Patients will continue to receive uninterrupted services, while referring providers and payors will experience enhanced support as the organization consolidates systems and operational processes.
Brand identity, digital systems, and platform-level technologies are currently under review, and the unified brand name will be revealed at a later date.
Legal and Advisory Support
- Holland & Knight served as legal counsel for AleraCare.
- Kunzler Bean & Adamson provided legal representation for Pure Healthcare.
- Cantor Fitzgerald acted as financial advisor to Pure Healthcare.
Leadership & Governance
The newly formed organization is led by Joe Cosgrove, who will serve as Chief Executive Officer.
The Board of Directors includes representation from Joe Cosgrove, Hildred, and Build Capital Partners, ensuring strong governance and strategic alignment as the company enters its next phase of growth.
